She is a Fellow of the Royal Society of Canada, Fellow of the Canadian Academy of Health Sciences, James McGill Professor and holds the Diane and Sal Guerrera Chair in Cancer Genetics at McGill. Dr. Park received a Bachelor of Science with first class honours from the University of Glasgow, a PhD in viral carcinogenesis at the Medical Research Council Virology Institute in Scotland and completed postdoctoral training at the National Institutes for Cancer Research in Washington DC.

She was the Director of the Molecular Oncology Group at the McGill University Hospital Centre (2006-8), Scientific Director of the Institute of Cancer Research for the CIHR (2008-13), co-chair of the Canadian Cancer Research Alliance (2008-2010) and is now Director of the Goodman Cancer Research Centre (2013-present). Dr. Park is a research leader in the field of receptor tyrosine kinases (RTK) and mechanisms of oncogenic activation of RTKs in human cancers. She has recently developed leadership in the breast cancer microenvironment. She is the elected chair of the Tumour Microenvironment Network of the American Association for Cancer Research (2015-2017). She is a recipient of a Canadian Cancer Research Alliance Award (2015) for Exceptional Leadership in Cancer Research, and also a recipient of the Canadian Society for Molecular Biosciences Arthur Wynne Gold Medal Prize (2016) for having made major contributions to biochemistry, molecular and cell biology in Canada. Most recently she is a recipient of the Canadian Cancer Society’s 2017 Robert L. Noble Prize. She has more than 200 publications.